Christopher Anderson, M.S., Ph.D.

Clinical Director

Dr. Christopher Anderson received his B.S. in Mechanical Engineering from the Rochester Institute of Technology and M.S. and Ph.D. in Biomedical Engineering from the University of Florida. He is currently a Research Assistant Professor in the Department of Neurology at the University of North Carolina at Chapel Hill and serves as the Director of Clinical Research for the Children's Translational Neuroscience Program. Previously he worked as a Clinical Engineer in the Carney Epilepsy Research Lab and as a Study Coordinator for the Department of Pediatrics at the University of Florida. Dr. Anderson's primary focus of research is with new drug development and the translation of preclinical studies to clinical trials. His work involves the initiation of clinical studies and oversight of all study related activity including patient care, data analysis, and regulatory control. Dr. Anderson's primary focus of research is with cannabinoids and related compounds as they relate to function and neurological change, and he is also actively involved in studies involving intractable and rare epilepsies, Alzheimer Disease, Neonatal Hypoxic Ischemic Encephalopathy, infantile spasms, tuberous sclerosis, and other related neurological disorders. Most recently, Dr. Anderson has successfully overseen and run a Florida Department of Health initiated trial intended to study the use of cannabidiol (CBD) for children with drug-resistant epilepsy.